Optimind Pharma

Optimind Pharma EBITDA per Share

EBITDA per Share of Optimind Pharma (OMND.CN) as of Oct 15, 2026.

EBITDA per Share

-0.00CAD

YoY

-74.20%

Last updated:

EBITDA per Share of Optimind Pharma is 2025 -0.00 CAD. EBITDA per Share of Optimind Pharma was 2024 -0.01 CAD. It decreases by -74.20% higher compared to the previous year.

The Optimind Pharma EBITDA per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA per Share
Date
EBITDA per Share
Jan 1, 2017
-0.09 CAD
Jan 1, 2018
-0.04 CAD
Jan 1, 2019
-0.01 CAD
Jan 1, 2020
-0.01 CAD
Jan 1, 2021
-0.02 CAD
Jan 1, 2023
-0.01 CAD
Jan 1, 2024
-0.01 CAD
Jan 1, 2025
-0.00 CAD
The Optimind Pharma EBITDA per Share history
YEAREBITDA per ShareYoY
-0.00CAD-74.20%
-0.01CAD-30.80%
-0.01CAD-35.74%
-0.02CAD+32.59%
-0.01CAD+87.63%
-0.01CAD-81.75%
-0.04CAD-58.08%
-0.09CAD+278.66%
-0.02CAD—
Access this data via the Eulerpool API
Get Free API Key

Optimind Pharma Stock analysis

What does Optimind Pharma do? Optimind Pharma is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Optimind Pharma stock

On Eulerpool you can find the complete historical development of EBITDA per Share Optimind Pharma since 2006 – with annual values, charts, and detailed analysis.

EBITDA per share divides EBITDA by shares outstanding, showing the operating cash earnings allocated to each share before depreciation and financing effects.

Access this data via the Eulerpool API
Get Free API Key

Income Statement — Optimind Pharma

RevenueGross ProfitEBITEBITDANet IncomeEPSCost of Goods SoldR&D ExpensesSG&A ExpensesOperating ExpensesInterest ExpensePretax IncomeTax ExpenseDepreciation & AmortizationRevenue per ShareEBIT per ShareDiluted EPSEBITDA per ShareOther Income/Expense

All Key Metrics — Optimind Pharma